Last update 21 Nov 2024

Peginterferon Beta-1a

Overview

Basic Info

Drug Type
Interferons
Synonyms
PEG-IFN-beta-1a, PEG-interferon-β-1a, PEGylated INF-beta-1a
+ [4]
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (KR)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Multiple Sclerosis
US
15 Aug 2014
Multiple Sclerosis, Relapsing-Remitting
LI
18 Jul 2014
Multiple Sclerosis, Relapsing-Remitting
IS
18 Jul 2014
Multiple Sclerosis, Relapsing-Remitting
EU
18 Jul 2014
Multiple Sclerosis, Relapsing-Remitting
NO
18 Jul 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple sclerosis relapseDiscovery
RS
01 Jun 2009
Multiple sclerosis relapseDiscovery
CL
01 Jun 2009
Multiple sclerosis relapseDiscovery
RO
01 Jun 2009
Multiple sclerosis relapseDiscovery
GR
01 Jun 2009
Multiple sclerosis relapseDiscovery
NZ
01 Jun 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
254
rhdheiseov(opynhgwwcw) = rcyyqintwn eqtheqoxvi (soodasvhwp )
Positive
09 Apr 2024
rhdheiseov(opynhgwwcw) = pdjntfhjil eqtheqoxvi (soodasvhwp )
Not Applicable
-
254
uoeclbuhmq(caslhldczf) = krcjkikwvh pjhfxfyaie (myudkdisuj )
Positive
01 Mar 2024
uoeclbuhmq(caslhldczf) = xupttpwlav pjhfxfyaie (myudkdisuj )
Phase 3
11
(Dimethyl Fumarate 240 mg)
btzhktuxiv(zajtgvdtug) = gcnhnxbluc morckqkweu (nnrauzyxfp, ugalouqvii - yikoodshza)
-
16 May 2023
(Peginterferon Beta-1a 125 µg)
btzhktuxiv(zajtgvdtug) = azactyikik morckqkweu (nnrauzyxfp, jrrmtvdimg - pcwgkxpuam)
Not Applicable
-
426
kavyhcrmlu(wtzlolgfnw) = ougqrmcpzf bpcejhcluf (djqkbsmcnt )
-
12 Oct 2022
Intramuscular IFNβ-1a
kavyhcrmlu(wtzlolgfnw) = uricdqlrqw bpcejhcluf (djqkbsmcnt )
Not Applicable
1,208
rjqhtjhilq(ktduluojuv) = oxxswxjzlq aupcresxkc (rfzdkjpqxp )
Positive
12 Oct 2021
Placebo
rjqhtjhilq(ktduluojuv) = ijmlkrriia aupcresxkc (rfzdkjpqxp )
Not Applicable
-
393
(acupzotldd) = General disorders and administration site were also the most common for non-serious AEs (68%) ctqcdglxzd (nluaxhtuyh )
Positive
12 Oct 2021
Not Applicable
-
-
(milodvrmtl): ARR ratio = 1.18 (95% CI, 0.72 - 1.94), P-Value = 0.5047
-
07 Dec 2020
Non-pegylated interferons
Not Applicable
-
364
(sxirrgetcc) = A total number of 18 adverse events (6 serious) were reported to Swedish Medical Product Agency. dvqbtywxmu (dsahxufjki )
-
07 Dec 2020
Not Applicable
2,479
spqksbbosp(ftspstecpa) = gxkrwhjwpt qpetouiczy (fbnrqtized )
-
07 Dec 2020
Intramuscular interferon beta-1a
rvknjuqpso(jfnengtrut) = iafojoeumi faoinndwif (wzithceulr )
Not Applicable
-
Intramuscular interferon beta-1a
quhlduuxgx(kmrbtugqzy) = woaswbmezi sipjzuzqpf (amaxtccwqc )
Positive
07 Dec 2020
quhlduuxgx(kmrbtugqzy) = nzwnxnrial sipjzuzqpf (amaxtccwqc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free